Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records

Ejemplares similares

• Data Mining of the Public Version of the FDA Adverse Event Reporting System
  por: Sakaeda, Toshiyuki, et al.
  Publicado: (2013)
• Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
  por: Sakaeda, Toshiyuki, et al.
  Publicado: (2011)
• Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
  por: Huang, Jing, et al.
  Publicado: (2020)
• Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
  por: Guo, Qiang, et al.
  Publicado: (2022)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  por: Meng, Long, et al.
  Publicado: (2021)